Thus, EBV specific immune control based on HLA-DRB1*1501 restricted CD4+ T cells could be less efficient in controlling EBV infection and stimulate autoimmunity in part via the resulting elevated levels of EBV transformed B cells. This evidence concerns the gene CD4 and Epstein-Barr virus infection.